[go: up one dir, main page]

GB202106361D0 - Viral vectored vaccines - Google Patents

Viral vectored vaccines

Info

Publication number
GB202106361D0
GB202106361D0 GBGB2106361.5A GB202106361A GB202106361D0 GB 202106361 D0 GB202106361 D0 GB 202106361D0 GB 202106361 A GB202106361 A GB 202106361A GB 202106361 D0 GB202106361 D0 GB 202106361D0
Authority
GB
United Kingdom
Prior art keywords
vectored vaccines
viral vectored
viral
vaccines
vectored
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2106361.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spybiotech Ltd
Original Assignee
Spybiotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spybiotech Ltd filed Critical Spybiotech Ltd
Priority to GBGB2106361.5A priority Critical patent/GB202106361D0/en
Publication of GB202106361D0 publication Critical patent/GB202106361D0/en
Priority to PCT/GB2022/051137 priority patent/WO2022234276A1/en
Priority to US18/558,898 priority patent/US20240240203A1/en
Priority to EP22723169.3A priority patent/EP4333864A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/761—Adenovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
GBGB2106361.5A 2021-05-04 2021-05-04 Viral vectored vaccines Ceased GB202106361D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB2106361.5A GB202106361D0 (en) 2021-05-04 2021-05-04 Viral vectored vaccines
PCT/GB2022/051137 WO2022234276A1 (en) 2021-05-04 2022-05-04 Adenoviral vectors and vaccines thereof
US18/558,898 US20240240203A1 (en) 2021-05-04 2022-05-04 Adenoviral vectors and vaccines thereof
EP22723169.3A EP4333864A1 (en) 2021-05-04 2022-05-04 Adenoviral vectors and vaccines thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2106361.5A GB202106361D0 (en) 2021-05-04 2021-05-04 Viral vectored vaccines

Publications (1)

Publication Number Publication Date
GB202106361D0 true GB202106361D0 (en) 2021-06-16

Family

ID=76301149

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2106361.5A Ceased GB202106361D0 (en) 2021-05-04 2021-05-04 Viral vectored vaccines

Country Status (1)

Country Link
GB (1) GB202106361D0 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011098772A1 (en) 2010-02-11 2011-08-18 Isis Innovation Limited Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
WO2016193746A1 (en) 2015-06-05 2016-12-08 Oxford University Innovation Limited Methods and products for fusion protein synthesis
WO2018189517A1 (en) 2017-04-10 2018-10-18 Oxford University Innovation Limited Peptide ligase and use thereof
WO2018197854A1 (en) 2017-04-24 2018-11-01 Oxford University Innovation Limited Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011098772A1 (en) 2010-02-11 2011-08-18 Isis Innovation Limited Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
WO2016193746A1 (en) 2015-06-05 2016-12-08 Oxford University Innovation Limited Methods and products for fusion protein synthesis
WO2018189517A1 (en) 2017-04-10 2018-10-18 Oxford University Innovation Limited Peptide ligase and use thereof
WO2018197854A1 (en) 2017-04-24 2018-11-01 Oxford University Innovation Limited Proteins and peptide tags with enhanced rate of spontaneous isopeptide bond formation and uses thereof

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BULDUN CMJEAN JXBEDFORD MRHOWARTH M: "SnoopLigase Catalyzes Peptide-Peptide Locking and Enables Solid-Phase Conjugate Isolation", J AM CHEM SOC., vol. 140, no. 8, 28 February 2018 (2018-02-28), pages 3008 - 3018
BULDUN, JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 140, no. 8, 2018, pages 3008 - 3018, Retrieved from the Internet <URL:https://pubs.acs.org/doi/10.1021/iacs.7b13237>
J. MAIZELD. WHITEM. SCHARFF: "The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12", VIROLOGY, vol. 36, September 1968 (1968-09-01), pages 115 - 125, XP023053253, DOI: 10.1016/0042-6822(68)90121-9
KEEBLE ET AL., PNAS, vol. 116, no. 52, 26 December 2019 (2019-12-26), pages 26523 - 26533, Retrieved from the Internet <URL:https://wwwpnasorg/content/116/52/26523.long>
LARSEN KCSPENCER AJGOODMAN ALGILCHRIST AFURZE JROLLIER CSKISS-TOTH EGILBERT SCBREGU MSOILLEUX EJ: "Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines", VACCINE, vol. 27, no. 41, 18 September 2009 (2009-09-18), pages 5589 - 98, XP026502236, DOI: 10.1016/j.vaccine.2009.07.025
LI L. ET AL., J. MOL. BIOL., vol. 426, 2014, pages 309 - 317
LI, L.FIERER, J. 0.RAPOPORT, T. A.HOWARTH, M.: "Structural analysis and optimization of the covalent association between SpyCatcher and a peptide Tag", J. MOL. BIOL., vol. 426, 2014, pages 309 - 317, XP028549188, DOI: 10.1016/j.jmb.2013.10.021
WARMING SCOSTANTINO NCOURT DLJENKINS NACOPELAND NG: "Simple and highly efficient BAC recombineering using galK selection", NUCLEIC ACIDS RES., vol. 33, no. 4, 2005, pages e36, XP002448125

Similar Documents

Publication Publication Date Title
GB2592769B (en) CpG-Adjuvanted SARS-CoV-2 virus vaccine
GB202010425D0 (en) Combination vaccine
GB202002166D0 (en) Vaccine
EP3743084A4 (en) RECOMBINANT ANTIVIRAL VACCINES
GB202004825D0 (en) Influenza vaccines
ES3030145T8 (en) Sars-cov-2 subunit vaccine
IL290924A (en) Hepatitis b virus vaccines
GB202106361D0 (en) Viral vectored vaccines
EP4429699A4 (en) Sars-cov-2 vaccines
ES3030310T8 (en) Sars-cov-2 subunit vaccine
GB202207281D0 (en) Vaccine
ZA202209826B (en) Inactivated sars-cov-2 virus vaccine
GB202112149D0 (en) Shigellla vaccine
GB202016954D0 (en) Vaccine
GB202315888D0 (en) Influenza vaccines
GB202213958D0 (en) Influenza vaccines
GB202208070D0 (en) Influenza vaccines
HK40111931A (en) Viral vaccine
GB202317925D0 (en) Vaccines
GB202116831D0 (en) Vaccines
GB202112499D0 (en) Beta-coronavirus vaccines
GB202201060D0 (en) Beta-coronavirus vaccines
GB202114328D0 (en) Influenza vaccines
GB202109285D0 (en) Beta-coronavirus vaccines
GB202314629D0 (en) Influenza virus vaccines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)